BioSpace News Archive

Pharm Country

PAVmed Announces Closing of Over-Allotment Option with Respect to Firm Commitment Common Stock Offering

The Firm Shares and the Option Shares were sold at a public offering price of $1.80 per share.

January 25, 2018
·
4 min read
Policy

CTI BioPharma Provides Corporate and European Regulatory Update

CTI BioPharma today announced that it has been reincorporated in the State of Delaware following a Special Meeting of Shareholders, triggering an automatic delisting of CTI’s common stock from the Borsa Italiana MTA exchange.

January 25, 2018
·
3 min read
Business

Charles River Laboratories Schedules Fourth-Quarter 2017 Earnings and 2018 Guidance Release and Conference Call

Charles River Laboratories International, Inc. will release fourth-quarter and full-year 2017 financial results and provide 2018 guidance on Tuesday, February 13th, before the market opens.

January 25, 2018
·
1 min read
Genetown

PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017

The Company reported GAAP losses per share from continuing operations of $0.35, including the impact of the Tax Cuts and Jobs Act of 2017, as compared to GAAP earnings per share from continuing operations of $0.57 in the fourth quarter of 2016.

January 25, 2018
·
35 min read
Biotech Bay

Bay Area’s ARMO BioSciences Raises $128M in IPO

The offering is expected to close on January 30, 2018, subject to customary closing conditions.

January 25, 2018
·
3 min read
Drug Development

GW Pharmaceuticals and Its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex (Cannabidiol) Study in The Lancet

Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior reported experience.

January 25, 2018
·
12 min read
Biotech Beach

REVA Announces First Implant of the Fantom Bioresorbable Scaffold in Italy

The procedure was conducted by Dr. Bernardo Cortese at the Fatebenefratelli Hospital in Milan.

January 25, 2018
·
4 min read
Drug Development

Adocia Announces Positive Topline Data From a Dose-Proportionality Study of BioChaperone Combo in People With Type 2 Diabetes

Adocia announced today positive topline results from a Phase 1b clinical trial.

January 25, 2018
·
5 min read
Drug Development

Orphazyme: Publication of Manuscript Related to Phase II Trial Results for Arimoclomol in Patients With SOD1 ALS

The manuscript highlights arimoclomol’s favorable safety profile and provides data on efficacy that supports the continued development of arimoclomol in a Phase II/III trial.

January 25, 2018
·
3 min read
Business

ConforMIS Announces Proposed Public Offering of Common Stock

Cowen and Canaccord Genuity are acting as joint book-running managers for the proposed offering.

January 25, 2018
·
4 min read